Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Total Liabilities (2019 - 2025)

Historic Total Liabilities for P3 Health Partners (PIII) over the last 7 years, with Q3 2025 value amounting to $664.6 million.

  • P3 Health Partners' Total Liabilities rose 1672.12% to $664.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $664.6 million, marking a year-over-year increase of 1672.12%. This contributed to the annual value of $633.9 million for FY2024, which is 4834.63% up from last year.
  • As of Q3 2025, P3 Health Partners' Total Liabilities stood at $664.6 million, which was up 1672.12% from $644.4 million recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' Total Liabilities ranged from a high of $664.6 million in Q3 2025 and a low of $6.0 million during Q1 2021
  • For the 5-year period, P3 Health Partners' Total Liabilities averaged around $391.1 million, with its median value being $395.9 million (2023).
  • In the last 5 years, P3 Health Partners' Total Liabilities soared by 557997.33% in 2022 and then soared by 1503.16% in 2023.
  • Quarter analysis of 5 years shows P3 Health Partners' Total Liabilities stood at $272.9 million in 2021, then grew by 29.68% to $353.9 million in 2022, then grew by 20.74% to $427.3 million in 2023, then surged by 48.35% to $633.9 million in 2024, then rose by 4.85% to $664.6 million in 2025.
  • Its last three reported values are $664.6 million in Q3 2025, $644.4 million for Q2 2025, and $662.8 million during Q1 2025.